Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial-Reference-Cited by-全球学者库

Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial

Published:2019-12-23 Issue:6 Volume:312 Page:437-445
ISSN:0340-3696
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Liu Lun-Fei,Chen Ji-Su,Gu Jun,Xu Jin-Hua,Jin Hong-Zhong,Pang Xiao-Wen,Wang Gang,Yu Chen,Song Zhi-Qiang,Guo Zai-Pei,Li Wei,Lai Wei,Cui Pan-Gen,Chen Min,Fang Hong,Lyu Cheng-Zhi,Li Yu-Zhen,Sun Qing,Xie Hong-Fu,Liu Xiao-Ming,Gao Xing-Hua,Shi Yu-Ling,Zhao Nai-Qing,Zhang Wei,Zheng Min^ORCID

Funder

Medical Health Science and Technology Project of Zhejiang Provincial Health Commission

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00403-019-02024-6.pdf

Reference25 articles.

1. Chen XX, Dai Q, Huang AB et al (2013) A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII: Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis. Clin Rheumatol 32:99–108

2. Davila-Seijo P, Dauden E, Descalzo MA et al (2017) Infections in moderate to severe psoriasis patients treated with biological drugs compared to classic systemic drugs: findings from the BIOBADADERM registry. J Investig Dermatol 137:313–321

3. Denadai R, Teixeira FV, Steinwurz F, Romiti R, Saad-Hossne R (2013) Induction or exacerbation of psoriatic lesions during anti-TNF-alpha therapy for inflammatory bowel disease: a systematic literature review based on 222 cases. J Crohns Colitis 7:517–524